Bruno Strigini

Bruno Strigini is the current Director at Owkin. Bruno has also served as the Chairman for Owkin, Senior Advisor for Permira, Director for Neuraxpharm, Partner for OneHealth Partners, and Chairman for Arvic-bio. Bruno has also been the Chief Executive Officer for Novartis Oncology and President for UCB. Bruno's previous companies include Merck, where they served as President for Europe and Canada, President for EUCAN II, and VP International Marketing for SmithKline Beecham. Bruno has also been the Managing Director for Fournier Pharma.

Bruno Strigini has an MBA from IMD Business School, a PharmD from Université Montpellier I, and an MSc in Microbiology from Heriot-Watt University.